Recombinant Dog Endothelial cell-specific chemotaxis regulator (ECSCR)

What is the basic structure and function of canine ECSCR?

Canine ECSCR is a single-transmembrane domain glycoprotein preferentially expressed in endothelial cells. It consists of an extracellular domain, a highly conserved transmembrane region, and a cytoplasmic domain that interacts with cytoskeletal proteins. The primary function of ECSCR involves regulating endothelial cell migration and cytoskeletal organization. The cytoplasmic domain interacts with the actin-binding protein filamin-A, the proteasome, and phosphatase and tensin homologue (PTEN), contributing to its regulatory functions in cell movement and angiogenesis .

How does ECSCR expression vary across different vascular beds in canines?

While specific data on canine vascular bed expression patterns is limited in the provided search results, studies in other species show that ECSCR is restricted primarily to major trunk and head vasculature. In mouse models, ECSCR appears present in the intersegmental vessels in addition to major vessels. By extension, canine ECSCR likely exhibits similar tissue-specific expression patterns, though researchers should perform immunohistochemical studies to confirm the exact distribution in canine tissues . This vascular bed-specific expression pattern has implications for experimental design when studying angiogenesis in different canine tissue contexts.

How can I validate the specificity of antibodies against canine ECSCR?

To validate antibodies against canine ECSCR, researchers should employ multiple complementary approaches. First, perform Western blotting with recombinant dog ECSCR as a positive control and lysates from cells known to express or lack ECSCR. Second, conduct immunoprecipitation followed by mass spectrometry to confirm target specificity. Third, use immunocytochemistry on transfected cells expressing tagged versions of ECSCR compared to mock-transfected controls. Finally, validate with siRNA-mediated knockdown of ECSCR to demonstrate reduction in antibody signal. Similar to biochemical assays described for human ECSCR, researchers should use radioimmune precipitation assay buffer to improve stringency of co-immunoprecipitation when studying ECSCR interactions .

What methods are most effective for achieving ECSCR overexpression in canine endothelial cells?

For effective overexpression of ECSCR in canine endothelial cells, researchers should consider: (1) Lentiviral transduction systems, which provide stable integration and expression in primary endothelial cells; (2) Electroporation-based methods, which can achieve high efficiency transfection in difficult-to-transfect endothelial cells; (3) Lipid-based transfection reagents optimized for endothelial cells when working with established cell lines. When designing expression constructs, include epitope tags (such as FLAG or HA) at the C-terminus to avoid interfering with the signal peptide. Researchers should verify expression using both RNA (qPCR) and protein (Western blot) analyses, as demonstrated in studies with human ECSCR . For functional studies, creating chimeric constructs with domains from other proteins like EMCN can help elucidate domain-specific functions.

How can I evaluate the effects of ECSCR knockdown in canine endothelial cells?

To evaluate ECSCR knockdown effects in canine endothelial cells, implement the following methodology: (1) Design siRNAs specifically targeting canine ECSCR sequences (similar to the approach used in human cells with siRNAs from Qiagen or Sigma); (2) Transfect primary canine endothelial cells using optimized protocols; (3) Confirm knockdown efficiency via qRT-PCR and Western blotting at 48-72 hours post-transfection; (4) Assess functional changes through multiple phenotypic assays including cell migration (Boyden chamber assays), cytoskeleton organization (phalloidin staining), and tubule formation on Matrigel . For analyzing VEGF signaling effects, measure phosphorylation of KDR, AKT, and ERK at various time points following VEGF stimulation, as ECSCR silencing disrupts VEGF-induced KDR activation and downstream phosphorylation events .

How does ECSCR influence canine endothelial cell migration and filopodia formation?

ECSCR plays a critical role in regulating canine endothelial cell migration through its interactions with cytoskeletal proteins. When ECSCR is overexpressed, it induces filopodia formation in cells containing filamin A, while cells lacking filamin A (such as M2 cells) fail to form filopodia despite ECSCR expression. This demonstrates that the ECSCR-filamin A interaction is crucial for filopodia formation . ECSCR loss causes cytoskeletal disorganization, directly impacting migration. Additionally, ECSCR modulates growth factor-mediated migration, including VEGF-induced responses. Mechanistically, ECSCR appears to inhibit certain migration pathways, such as bFGF-mediated cell migration via the FGFR-ERK-FAK pathway, while promoting cell aggregation . These complex effects highlight the context-dependent nature of ECSCR function in migration processes.

How does ECSCR interact with VEGF receptor signaling in canine endothelial cells?

ECSCR selectively interacts with KDR (VEGF receptor 2) but not with FLT1 (VEGF receptor 1) in endothelial cells. This interaction involves both the transmembrane domain and the cytoplasmic region of ECSCR. VEGF165 stimulation rapidly and transiently increases ECSCR-KDR complex formation, a process that can be blocked by KDR tyrosine kinase inhibitor SU5416 or inhibitors of endosomal acidification . Functionally, ECSCR is required for full KDR activation, as silencing of ECSCR disrupts VEGF-induced KDR activation and downstream AKT and ERK phosphorylation. Furthermore, ECSCR depletion impairs VEGF-stimulated KDR degradation, suggesting it has dual roles: in resting cells, basal association increases KDR activation, while in stimulated cells, a delayed association enhances KDR degradation . This complex relationship indicates ECSCR is a significant modulator of VEGF signaling in canine endothelial cells.

Which cytoskeletal proteins interact with canine ECSCR and how can these interactions be studied?

Canine ECSCR interacts with several cytoskeletal proteins, primarily filamin A and moesin, which are involved in cell movement and cytoskeletal organization. To study these interactions, researchers should employ co-immunoprecipitation assays using radioimmune precipitation assay buffer to improve stringency, followed by Western blotting . For visualizing these interactions, immunofluorescence microscopy with co-localization analysis can be performed using antibodies against ECSCR and its binding partners. To identify novel interaction partners, mass spectrometry analysis of ECSCR immunoprecipitates can reveal additional cytoskeletal proteins. Functional validation of these interactions should include mutagenesis studies targeting specific domains of ECSCR, followed by co-immunoprecipitation and cell-based assays examining cytoskeletal organization and filopodia formation . The interaction between ECSCR and filamin A appears particularly important, as evidenced by the inability of ECSCR to induce filopodia in M2 cells lacking filamin A.

How does ECSCR modulate inflammatory signaling pathways in canine endothelial cells?

While direct evidence for ECSCR's role in canine inflammatory signaling is limited in the provided search results, inference can be made from studies on inflammatory mediators in canine endothelial cells. Inflammatory mediators like LPS and TNF-α regulate endothelial adhesion molecules and might intersect with ECSCR functions . ECSCR appears to attenuate certain signaling pathways, potentially including those involved in inflammation. It may inhibit the Shc-Ras-ERK (MAPKinase) pathway and could cross-talk with receptors like EGFR . For investigating ECSCR's role in inflammation, researchers should examine how ECSCR expression affects responses to inflammatory stimuli such as TNF-α, which is known to regulate endothelial adhesion molecule expression in canine cells . Time-course experiments measuring inflammatory marker expression (e.g., ICAM-1, selectins) in ECSCR-manipulated cells would provide insights into this relationship.

How can chimeric receptor constructs be used to determine domain-specific functions of canine ECSCR?

Chimeric receptor constructs provide powerful tools for dissecting domain-specific functions of canine ECSCR. Researchers should design chimeras by swapping discrete domains between ECSCR and structurally similar but functionally distinct proteins like endomucin (EMCN). Following the approach demonstrated with human ECSCR, constructs can include: (1) ECSCR extracellular and transmembrane domains with EMCN cytoplasmic tail (EC/EM); (2) EMCN extracellular and transmembrane domains with ECSCR cytoplasmic tail (EM/EC); and (3) EMCN-derived protein containing only the ECSCR transmembrane domain (TMswap) . These constructs should be expressed in endothelial cells or relevant model systems, followed by functional assays including co-immunoprecipitation with potential binding partners, migration assays, filopodia formation assessment, and signaling pathway activation . This approach revealed that both the transmembrane and cytoplasmic domains of human ECSCR can independently contribute to KDR association, suggesting similar domain functions might exist in canine ECSCR.

What are the methodological considerations for studying ECSCR-KDR co-localization in canine endothelial cells?

To study ECSCR-KDR co-localization in canine endothelial cells, researchers should implement triple labeling experiments similar to those conducted with human cells. This methodological approach requires: (1) Primary antibodies specific to canine ECSCR and KDR from different host species to avoid cross-reactivity; (2) Fluorescently-labeled secondary antibodies with non-overlapping emission spectra; (3) A third marker for cellular compartments (e.g., EEA1 for early endosomes); (4) Confocal microscopy with appropriate controls for spectral bleed-through; and (5) Quantitative co-localization analysis software . Time-course experiments following VEGF stimulation (0-30 minutes) should be performed, as VEGF165 transiently increases ECSCR-KDR complex formation with peak association around 10 minutes post-stimulation, followed by a return to basal levels by 30 minutes . For biochemical validation, perform subcellular fractionation to isolate membrane and endosomal compartments, followed by co-immunoprecipitation from each fraction.

How can I design experiments to investigate the effect of ECSCR on angiogenesis in canine models?

To investigate ECSCR's effect on angiogenesis in canine models, design a comprehensive experimental approach incorporating in vitro, ex vivo, and in vivo methodologies. For in vitro studies, establish ECSCR-overexpressing and ECSCR-knockdown canine endothelial cell lines to assess tubule formation on Matrigel, sprouting in 3D fibrin gels, and response to angiogenic factors like VEGF . For ex vivo approaches, employ canine aortic ring assays with ECSCR modulation using viral vectors or neutralizing antibodies. For in vivo studies, consider developing canine-relevant angiogenesis models such as matrigel plug assays or wound healing models with local ECSCR manipulation. Based on zebrafish knockdown studies where ECSCR loss disrupted intersegmental vessel sprouting, researchers should focus on similar developing vascular beds in canine models . Additionally, investigate ECSCR's interaction with VEGF signaling by examining how ECSCR modulation affects responses to VEGF in these model systems, as ECSCR enhances VEGF receptor KDR activation .

How does canine ECSCR compare structurally and functionally to human and murine ECSCR?

Canine ECSCR likely shares significant structural and functional similarities with human and murine homologs, given the highly conserved nature of the transmembrane and cytoplasmic sequences observed across species. While the search results don't provide specific sequence comparisons for canine ECSCR, human ECSCR is characterized as a single-transmembrane domain glycoprotein with conserved functional domains . Functionally, ECSCR appears to play similar roles across species in regulating endothelial cell migration, cytoskeletal organization, and angiogenesis. In zebrafish, ECSCR knockdown disrupts intersegmental vessel sprouting, while in mice, ECSCR knockout results in non-lethal bleeding during embryogenesis and increased small vessel density . Species differences may exist in expression patterns, as murine ECSCR appears present in intersegmental vessels, while zebrafish ECSCR is restricted to major trunk and head vasculature . To comprehensively compare canine ECSCR with other species, researchers should perform sequence alignment, domain prediction, and cross-species functional rescue experiments.

What experimental systems are optimal for studying species-specific aspects of ECSCR function?

For studying species-specific aspects of ECSCR function, researchers should employ multiple complementary experimental systems. Cell-based systems should include: (1) Primary canine endothelial cells for authentic signaling contexts; (2) Heterologous expression systems like PAE cells, which express low levels of VEGF co-receptors, allowing study of ECSCR in relative isolation ; and (3) Cross-species rescue experiments where canine ECSCR is expressed in human or mouse ECSCR-knockout cells to assess functional conservation. For molecular interaction studies, recombinant protein production systems should express the canine ECSCR extracellular domain, transmembrane domain, and cytoplasmic region separately to identify species-specific binding partners through pull-down assays . For in vivo studies, chimeric mouse models expressing canine ECSCR under endothelial-specific promoters in ECSCR-knockout mice could reveal species-specific functions. In all systems, researchers should focus on comparative analyses of ECSCR's interaction with KDR, as this partnership appears central to ECSCR function across species .

How do VEGF-induced ECSCR-KDR interactions compare between canine and human endothelial cells?

While the search results don't provide direct comparative data between canine and human VEGF-induced ECSCR-KDR interactions, important insights can be extrapolated from human studies. In human endothelial cells, VEGF165 stimulation rapidly and transiently increases ECSCR-KDR complex formation, peaking around 10 minutes and returning to basal levels by 30 minutes . This interaction is dependent on KDR kinase activity, as it can be blocked by the inhibitor SU5416 . The specificity of interaction appears preserved across species, with ECSCR selectively associating with KDR but not FLT1. To directly compare these interactions between species, researchers should perform parallel time-course experiments in both canine and human endothelial cells using standardized VEGF stimulation protocols (10-50 ng/ml VEGF165) and assess co-immunoprecipitation efficiency, co-localization patterns, and downstream signaling consequences. Potential species-specific differences might emerge in the kinetics of association, subcellular localization patterns, or the effect of different VEGF isoforms on complex formation .

How can I optimize protein extraction protocols for detecting low-abundance ECSCR in canine tissues?

To optimize protein extraction for low-abundance ECSCR detection in canine tissues, implement a multi-step approach: (1) Immediately flash-freeze tissue samples in liquid nitrogen after collection to prevent protein degradation; (2) Employ a specialized extraction buffer containing 1% NP-40 or Triton X-100, 150 mM NaCl, 50 mM Tris-HCl (pH 7.4), protease inhibitor cocktail, and phosphatase inhibitors; (3) Include membrane protein enrichment steps such as ultracentrifugation to concentrate transmembrane proteins like ECSCR; (4) Consider using specialized commercial kits designed for membrane protein extraction; (5) For immunoprecipitation, use radioimmune precipitation assay buffer to improve stringency as described for human ECSCR studies ; and (6) Employ signal amplification techniques like enhanced chemiluminescence substrates for Western blotting. For tissue sections, antigen retrieval optimization is critical - test multiple methods including heat-induced epitope retrieval with citrate buffer (pH 6.0) and enzymatic retrieval with proteinase K to determine optimal conditions for canine ECSCR detection.

What are the common pitfalls when studying ECSCR-protein interactions and how can they be avoided?

Common pitfalls when studying ECSCR-protein interactions include: (1) Weak or transient interactions being missed during standard co-immunoprecipitation; (2) Non-specific binding giving false positive results; (3) Epitope masking during complex formation; and (4) Disruption of physiologically relevant complexes during cell lysis. To overcome these challenges, researchers should: (1) Use crosslinking reagents like DSP (dithiobis(succinimidyl propionate)) to stabilize transient interactions; (2) Include appropriate controls including isotype-matched irrelevant antibodies and lysates from cells not expressing ECSCR; (3) Test multiple antibodies targeting different epitopes of ECSCR; (4) Optimize lysis conditions using buffers of varying stringency; and (5) Complement biochemical approaches with proximity ligation assays to detect interactions in intact cells . For detecting ECSCR-KDR interactions specifically, researchers should be aware that VEGF stimulation enhances complex formation transiently (peaking at 10 minutes), and this enhancement can be blocked by kinase inhibitors or endosomal acidification inhibitors .

How can discrepancies in ECSCR functional data be reconciled in experimental design?

To reconcile discrepancies in ECSCR functional data across studies, researchers should implement a systematic experimental design approach: (1) Standardize experimental conditions including cell types, passage numbers, culture conditions, and reagent concentrations; (2) Employ multiple methodologies to assess each functional endpoint - for example, when studying migration, use both Boyden chamber and wound healing assays; (3) Perform dose-response and time-course experiments rather than single-point measurements; (4) Include appropriate positive and negative controls in all experiments; and (5) Explicitly account for context-dependent effects by varying experimental parameters systematically . Additionally, researchers should carefully consider that ECSCR appears to have context-dependent effects - in some cases inhibiting certain migration pathways while promoting others. For instance, ECSCR can inhibit bFGF-mediated cell migration while differentially affecting VEGF-mediated responses . This functional complexity may explain apparent discrepancies in the literature and underscores the importance of precisely defining experimental conditions when comparing results across studies.